Japanese clinical practice guidelines for allied disorders of Hirschsprung's disease, 2017

Mitsuru Muto, Hiroshi Matsufuji, Tomoaki Taguchi, Takeshi Tomomasa, Masaki Nio, Hiroshi Tamai, Masanori Tamura, Haruhiko Sago, Akira Toki, Shunsuke Nosaka, Tatsuo Kuroda, Masahiro Yoshida, Atsushi Nakajima, Hiroyuki Kobayashi, Hideki Sou, Kouji Masumoto, Yoshio Watanabe, Yutaka Kanamori, Yoshinori Hamada, Atsuyuki Yamataka & 22 others Naoki Shimojima, Akio Kubota, Kosuke Ushijima, Ken Haruma, Shin Fukudo, Yuko Araki, Takahiro Kudo, Satoshi Obata, Wataru Sumita, Toshihiko Watanabe, Suguru Fukahori, Yoshimitsu Fujii, Yoshiyuki Yamada, Keisuke Jimbo, Fujimi Kawai, Tomoya Fukuoka, Shinsuke Onuma, Toshio Morizane, Satoshi Ieiri, Genshiro Esumi, Takahiro Jimbo, Tomoko Yamasaki

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: Despite the presence of ganglion cells in the rectum, some patients have symptoms similar to those of Hirschsprung's disease. A consensus has yet to be established regarding the terminology for these diseases. We defined this group of diseases as “allied disorders of Hirschsprung's disease” and compiled these guidelines to facilitate accurate clinician diagnosis and provide appropriate treatment strategies for each disease. Methods: These guidelines were developed using the methodologies in the Medical Information Network Distribution System (MINDS). Of seven allied disorders, isolated hypoganglionosis; megacystis-microcolon-intestinal hypoperistalsis syndrome; and chronic idiopathic intestinal pseudo-obstruction were selected as targets of clinical questions (CQ). In a comprehensive search of the Japanese- and English-language articles in PubMed and Ichu-Shi Web, 836 pieces of evidence related to the CQ were extracted from 288 articles; these pieces of evidence were summarized in an evidence table. Results: We herein outline the newly established Japanese clinical practice guidelines for allied disorders of Hirschsprung's disease. Given that the target diseases are rare and intractable, most evidence was drawn from case reports and case series. In the CQ, the diagnosis, medication, nutritional support, surgical therapy, and prognosis for each disease are given. We emphasize the importance of full-thickness intestinal biopsy specimens for the histopathological evaluation of enteric ganglia. Considering the practicality of the guidelines, the recommendations for each CQ were created with protracted discussions among specialists. Conclusions: Clinical practice recommendations for allied disorders of Hirschprung's disease are given for each CQ, along with an assessment of the current evidence. We hope that the information will be helpful in daily practice and future studies.

Original languageEnglish
Pages (from-to)400-410
Number of pages11
JournalPediatrics International
Volume60
Issue number5
DOIs
Publication statusPublished - May 1 2018

Fingerprint

Hirschsprung Disease
Practice Guidelines
Guidelines
Ganglia
Intestinal Pseudo-Obstruction
Information Services
Nutritional Support
Information Dissemination
Rare Diseases
Rectum
PubMed
Terminology
Consensus
Language
Biopsy
Therapeutics

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health

Cite this

Japanese clinical practice guidelines for allied disorders of Hirschsprung's disease, 2017. / Muto, Mitsuru; Matsufuji, Hiroshi; Taguchi, Tomoaki; Tomomasa, Takeshi; Nio, Masaki; Tamai, Hiroshi; Tamura, Masanori; Sago, Haruhiko; Toki, Akira; Nosaka, Shunsuke; Kuroda, Tatsuo; Yoshida, Masahiro; Nakajima, Atsushi; Kobayashi, Hiroyuki; Sou, Hideki; Masumoto, Kouji; Watanabe, Yoshio; Kanamori, Yutaka; Hamada, Yoshinori; Yamataka, Atsuyuki; Shimojima, Naoki; Kubota, Akio; Ushijima, Kosuke; Haruma, Ken; Fukudo, Shin; Araki, Yuko; Kudo, Takahiro; Obata, Satoshi; Sumita, Wataru; Watanabe, Toshihiko; Fukahori, Suguru; Fujii, Yoshimitsu; Yamada, Yoshiyuki; Jimbo, Keisuke; Kawai, Fujimi; Fukuoka, Tomoya; Onuma, Shinsuke; Morizane, Toshio; Ieiri, Satoshi; Esumi, Genshiro; Jimbo, Takahiro; Yamasaki, Tomoko.

In: Pediatrics International, Vol. 60, No. 5, 01.05.2018, p. 400-410.

Research output: Contribution to journalArticle

Muto, M, Matsufuji, H, Taguchi, T, Tomomasa, T, Nio, M, Tamai, H, Tamura, M, Sago, H, Toki, A, Nosaka, S, Kuroda, T, Yoshida, M, Nakajima, A, Kobayashi, H, Sou, H, Masumoto, K, Watanabe, Y, Kanamori, Y, Hamada, Y, Yamataka, A, Shimojima, N, Kubota, A, Ushijima, K, Haruma, K, Fukudo, S, Araki, Y, Kudo, T, Obata, S, Sumita, W, Watanabe, T, Fukahori, S, Fujii, Y, Yamada, Y, Jimbo, K, Kawai, F, Fukuoka, T, Onuma, S, Morizane, T, Ieiri, S, Esumi, G, Jimbo, T & Yamasaki, T 2018, 'Japanese clinical practice guidelines for allied disorders of Hirschsprung's disease, 2017', Pediatrics International, vol. 60, no. 5, pp. 400-410. https://doi.org/10.1111/ped.13559
Muto, Mitsuru ; Matsufuji, Hiroshi ; Taguchi, Tomoaki ; Tomomasa, Takeshi ; Nio, Masaki ; Tamai, Hiroshi ; Tamura, Masanori ; Sago, Haruhiko ; Toki, Akira ; Nosaka, Shunsuke ; Kuroda, Tatsuo ; Yoshida, Masahiro ; Nakajima, Atsushi ; Kobayashi, Hiroyuki ; Sou, Hideki ; Masumoto, Kouji ; Watanabe, Yoshio ; Kanamori, Yutaka ; Hamada, Yoshinori ; Yamataka, Atsuyuki ; Shimojima, Naoki ; Kubota, Akio ; Ushijima, Kosuke ; Haruma, Ken ; Fukudo, Shin ; Araki, Yuko ; Kudo, Takahiro ; Obata, Satoshi ; Sumita, Wataru ; Watanabe, Toshihiko ; Fukahori, Suguru ; Fujii, Yoshimitsu ; Yamada, Yoshiyuki ; Jimbo, Keisuke ; Kawai, Fujimi ; Fukuoka, Tomoya ; Onuma, Shinsuke ; Morizane, Toshio ; Ieiri, Satoshi ; Esumi, Genshiro ; Jimbo, Takahiro ; Yamasaki, Tomoko. / Japanese clinical practice guidelines for allied disorders of Hirschsprung's disease, 2017. In: Pediatrics International. 2018 ; Vol. 60, No. 5. pp. 400-410.
@article{a25f88a0a3da4c5f9086bf1153a6b041,
title = "Japanese clinical practice guidelines for allied disorders of Hirschsprung's disease, 2017",
abstract = "Background: Despite the presence of ganglion cells in the rectum, some patients have symptoms similar to those of Hirschsprung's disease. A consensus has yet to be established regarding the terminology for these diseases. We defined this group of diseases as “allied disorders of Hirschsprung's disease” and compiled these guidelines to facilitate accurate clinician diagnosis and provide appropriate treatment strategies for each disease. Methods: These guidelines were developed using the methodologies in the Medical Information Network Distribution System (MINDS). Of seven allied disorders, isolated hypoganglionosis; megacystis-microcolon-intestinal hypoperistalsis syndrome; and chronic idiopathic intestinal pseudo-obstruction were selected as targets of clinical questions (CQ). In a comprehensive search of the Japanese- and English-language articles in PubMed and Ichu-Shi Web, 836 pieces of evidence related to the CQ were extracted from 288 articles; these pieces of evidence were summarized in an evidence table. Results: We herein outline the newly established Japanese clinical practice guidelines for allied disorders of Hirschsprung's disease. Given that the target diseases are rare and intractable, most evidence was drawn from case reports and case series. In the CQ, the diagnosis, medication, nutritional support, surgical therapy, and prognosis for each disease are given. We emphasize the importance of full-thickness intestinal biopsy specimens for the histopathological evaluation of enteric ganglia. Considering the practicality of the guidelines, the recommendations for each CQ were created with protracted discussions among specialists. Conclusions: Clinical practice recommendations for allied disorders of Hirschprung's disease are given for each CQ, along with an assessment of the current evidence. We hope that the information will be helpful in daily practice and future studies.",
author = "Mitsuru Muto and Hiroshi Matsufuji and Tomoaki Taguchi and Takeshi Tomomasa and Masaki Nio and Hiroshi Tamai and Masanori Tamura and Haruhiko Sago and Akira Toki and Shunsuke Nosaka and Tatsuo Kuroda and Masahiro Yoshida and Atsushi Nakajima and Hiroyuki Kobayashi and Hideki Sou and Kouji Masumoto and Yoshio Watanabe and Yutaka Kanamori and Yoshinori Hamada and Atsuyuki Yamataka and Naoki Shimojima and Akio Kubota and Kosuke Ushijima and Ken Haruma and Shin Fukudo and Yuko Araki and Takahiro Kudo and Satoshi Obata and Wataru Sumita and Toshihiko Watanabe and Suguru Fukahori and Yoshimitsu Fujii and Yoshiyuki Yamada and Keisuke Jimbo and Fujimi Kawai and Tomoya Fukuoka and Shinsuke Onuma and Toshio Morizane and Satoshi Ieiri and Genshiro Esumi and Takahiro Jimbo and Tomoko Yamasaki",
year = "2018",
month = "5",
day = "1",
doi = "10.1111/ped.13559",
language = "English",
volume = "60",
pages = "400--410",
journal = "Pediatrics International",
issn = "1328-8067",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Japanese clinical practice guidelines for allied disorders of Hirschsprung's disease, 2017

AU - Muto, Mitsuru

AU - Matsufuji, Hiroshi

AU - Taguchi, Tomoaki

AU - Tomomasa, Takeshi

AU - Nio, Masaki

AU - Tamai, Hiroshi

AU - Tamura, Masanori

AU - Sago, Haruhiko

AU - Toki, Akira

AU - Nosaka, Shunsuke

AU - Kuroda, Tatsuo

AU - Yoshida, Masahiro

AU - Nakajima, Atsushi

AU - Kobayashi, Hiroyuki

AU - Sou, Hideki

AU - Masumoto, Kouji

AU - Watanabe, Yoshio

AU - Kanamori, Yutaka

AU - Hamada, Yoshinori

AU - Yamataka, Atsuyuki

AU - Shimojima, Naoki

AU - Kubota, Akio

AU - Ushijima, Kosuke

AU - Haruma, Ken

AU - Fukudo, Shin

AU - Araki, Yuko

AU - Kudo, Takahiro

AU - Obata, Satoshi

AU - Sumita, Wataru

AU - Watanabe, Toshihiko

AU - Fukahori, Suguru

AU - Fujii, Yoshimitsu

AU - Yamada, Yoshiyuki

AU - Jimbo, Keisuke

AU - Kawai, Fujimi

AU - Fukuoka, Tomoya

AU - Onuma, Shinsuke

AU - Morizane, Toshio

AU - Ieiri, Satoshi

AU - Esumi, Genshiro

AU - Jimbo, Takahiro

AU - Yamasaki, Tomoko

PY - 2018/5/1

Y1 - 2018/5/1

N2 - Background: Despite the presence of ganglion cells in the rectum, some patients have symptoms similar to those of Hirschsprung's disease. A consensus has yet to be established regarding the terminology for these diseases. We defined this group of diseases as “allied disorders of Hirschsprung's disease” and compiled these guidelines to facilitate accurate clinician diagnosis and provide appropriate treatment strategies for each disease. Methods: These guidelines were developed using the methodologies in the Medical Information Network Distribution System (MINDS). Of seven allied disorders, isolated hypoganglionosis; megacystis-microcolon-intestinal hypoperistalsis syndrome; and chronic idiopathic intestinal pseudo-obstruction were selected as targets of clinical questions (CQ). In a comprehensive search of the Japanese- and English-language articles in PubMed and Ichu-Shi Web, 836 pieces of evidence related to the CQ were extracted from 288 articles; these pieces of evidence were summarized in an evidence table. Results: We herein outline the newly established Japanese clinical practice guidelines for allied disorders of Hirschsprung's disease. Given that the target diseases are rare and intractable, most evidence was drawn from case reports and case series. In the CQ, the diagnosis, medication, nutritional support, surgical therapy, and prognosis for each disease are given. We emphasize the importance of full-thickness intestinal biopsy specimens for the histopathological evaluation of enteric ganglia. Considering the practicality of the guidelines, the recommendations for each CQ were created with protracted discussions among specialists. Conclusions: Clinical practice recommendations for allied disorders of Hirschprung's disease are given for each CQ, along with an assessment of the current evidence. We hope that the information will be helpful in daily practice and future studies.

AB - Background: Despite the presence of ganglion cells in the rectum, some patients have symptoms similar to those of Hirschsprung's disease. A consensus has yet to be established regarding the terminology for these diseases. We defined this group of diseases as “allied disorders of Hirschsprung's disease” and compiled these guidelines to facilitate accurate clinician diagnosis and provide appropriate treatment strategies for each disease. Methods: These guidelines were developed using the methodologies in the Medical Information Network Distribution System (MINDS). Of seven allied disorders, isolated hypoganglionosis; megacystis-microcolon-intestinal hypoperistalsis syndrome; and chronic idiopathic intestinal pseudo-obstruction were selected as targets of clinical questions (CQ). In a comprehensive search of the Japanese- and English-language articles in PubMed and Ichu-Shi Web, 836 pieces of evidence related to the CQ were extracted from 288 articles; these pieces of evidence were summarized in an evidence table. Results: We herein outline the newly established Japanese clinical practice guidelines for allied disorders of Hirschsprung's disease. Given that the target diseases are rare and intractable, most evidence was drawn from case reports and case series. In the CQ, the diagnosis, medication, nutritional support, surgical therapy, and prognosis for each disease are given. We emphasize the importance of full-thickness intestinal biopsy specimens for the histopathological evaluation of enteric ganglia. Considering the practicality of the guidelines, the recommendations for each CQ were created with protracted discussions among specialists. Conclusions: Clinical practice recommendations for allied disorders of Hirschprung's disease are given for each CQ, along with an assessment of the current evidence. We hope that the information will be helpful in daily practice and future studies.

UR - http://www.scopus.com/inward/record.url?scp=85047843771&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047843771&partnerID=8YFLogxK

U2 - 10.1111/ped.13559

DO - 10.1111/ped.13559

M3 - Article

VL - 60

SP - 400

EP - 410

JO - Pediatrics International

JF - Pediatrics International

SN - 1328-8067

IS - 5

ER -